International Journal of Health and Clinical Research

International Journal of Health and Clinical Research

Mucormycosis In Covid-19 Pandemic

Yazarlar: Chandni Malhotra, Sachi Gupta, Sachit Mahajan, Satish Kumar Gupta

Cilt 5 , Sayı 2 , 2022 , Sayfalar 208-211

Konular:-

Anahtar Kelimeler:Mucormycosis,Uncontrolled Diabetes,Severe Acute Respiratory Syndrome Coronavirus 2,COVID,9.

Özet: Mucormycosis (Zygomycosis) is an invasive fungal infection. It typically affects immune compromised individuals with an impaired neutrophilic response. There are several case reports of Rhino-orbital-cerebral mucormycosis (ROCM) from all over the world. Recently, its alarming rise in the number amongCOVID-19 patients mostly with uncontrolled diabetes and those who received excessive administration ofsteroids for the treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection hasraised interest among the scientific community to learn more about the said disease. The current reviewdescribes, its epidemiology, clinical presentation, risk factors, warning signs, diagnostic test and available preventive and treatment modalities for its effective management.


ATIFLAR
Atıf Yapan Eserler
Henüz Atıf Yapılmamıştır

KAYNAK GÖSTER
BibTex
KOPYALA
@article{2022, title={Mucormycosis In Covid-19 Pandemic}, volume={5}, number={208–211}, publisher={International Journal of Health and Clinical Research}, author={Chandni Malhotra,Sachi Gupta,Sachit Mahajan,Satish Kumar Gupta}, year={2022} }
APA
KOPYALA
Chandni Malhotra,Sachi Gupta,Sachit Mahajan,Satish Kumar Gupta. (2022). Mucormycosis In Covid-19 Pandemic (Vol. 5). Vol. 5. International Journal of Health and Clinical Research.
MLA
KOPYALA
Chandni Malhotra,Sachi Gupta,Sachit Mahajan,Satish Kumar Gupta. Mucormycosis In Covid-19 Pandemic. no. 208–211, International Journal of Health and Clinical Research, 2022.